International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 5 , Pages 1372-1380 , 1 August 2008

Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability

  • Albert Lai, M.D., Ph.D.

      Affiliations

    • Department of Neurology, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • Corresponding Author InformationReprint requests to: Albert Lai, M.D., Ph.D., UCLA Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Suite 1-230 RNRC, Los Angeles, CA 90095. Tel: (310) 825-5321; Fax: (310) 825-0644
    • ,
  • Emese Filka

      Affiliations

    • Department of Neurology, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • ,
  • Bruce McGibbon, M.D.

      Affiliations

    • Department of Radiation Oncology, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • ,
  • Phioanh Leia Nghiemphu, M.D.

      Affiliations

    • Department of Neurology, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • ,
  • Carrie Graham

      Affiliations

    • Department of Neurology, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • ,
  • William H. Yong, M.D.

      Affiliations

    • Department of Pathology, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • ,
  • Paul Mischel, M.D.

      Affiliations

    • Department of Pathology, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • ,
  • Linda M. Liau, M.D., Ph.D.

      Affiliations

    • Department of Neurosurgery, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • ,
  • Marvin Bergsneider, M.D.

      Affiliations

    • Department of Neurosurgery, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • ,
  • Whitney Pope, M.D., Ph.D.

      Affiliations

    • Department of Radiology, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • ,
  • Michael Selch, M.D.

      Affiliations

    • Department of Radiation Oncology, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA
    • ,
  • Tim Cloughesy, M.D.

      Affiliations

    • Department of Neurology, David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, CA

Received 4 October 2007 ,Revised 29 November 2007 ,Accepted 30 November 2007.

References 

  1. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: Current concepts and review of the literature. Neuro-Oncol. 2002;4:278–299
  2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996
  3. Vredenburgh JJ, Desjardins A, Herndon JE, et al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res. 2007;13:1253–1259
  4. Pope WB, Lai A, Nghiemphu P, et al. MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology. 2006;66:1258–1260
  5. Carlson MR, Pope WB, Horvath S, et al. Relationship between survival and edema in malignant gliomas: Role of vascular endothelial growth factor and neuronal pentraxin 2. Clin Cancer Res. 2007;13:2592–2598
  6. Steiner H-H, Karcher S, Mueller MM, et al. Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: Clinical relevance of radiation-induced increase of VEGF levels. J Neuro-Oncol. 2004;66:129–138
  7. Senan S, Smit EF. Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist. 2007;12:465–477
  8. Hovinga K, Stalpers L, Bree C, et al. Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines—a clue to radioresistance?. J Neuro-Oncol. 2005;74:99–103
  9. Wachsberger PR, Burd R, Cardi C, et al. VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma. Int J Radiat Oncol Biol Phys. 2007;67:1526–1537
  10. Nieder C, Wiedenmann N, Andratschke N, et al. Current status of angiogenesis inhibitors combined with radiation therapy. Cancer Treat Rev. 2006;32:348–364
  11. Winkler F, Kozin SV, Tong RT, et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell. 2004;6:553–563
  12. Wong CS, Van der Kogel AJ. Mechanisms of radiation injury to the central nervous system: Implications for neuroprotection. Mol Interv. 2004;4:273–284
  13. Zachary I. Neuroprotective role of vascular endothelial growth factor: Signalling mechanisms, biological function, and therapeutic potential. Neurosignals. 2005;14:207–221
  14. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  15. Parsons JT, Bova FJ, Fitzgerald CR, et al. Radiation retinopathy after external-beam irradiation: Analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994;30:765–773
  16. Gerber DE, Grossman SA, Zeltzman M, et al. The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Neuro-Oncol. 2007;9:47–52
  17. Kabbinavar F, Hurwitz HI, Fehrenbacher L, et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol. 2003;21:60–65
  18. Scappaticci FA, Fehrenbacher L, Cartwright T, et al. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol. 2005;91:173–180
  19. Chang SM, Parney IF, McDermott M, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003;98:1175–1181
  20. Smith SF, Simpson JM, Sekhon LH. What progress has been made in surgical management of patients with astrocytoma and oligodendroglioma in Australia over the last two decades?. J Clin Neurosci. 2005;12:915–920discussion 921
  21. Lawson HC, Sampath P, Bohan E, et al. Interstitial chemotherapy for malignant gliomas: The Johns Hopkins experience. J Neurooncol. 2007;83:61–70
  22. Czito BG, Bendell JC, Willett CG, et al. Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. Int J Radiat Oncol Biol Phys. 2007;68:472–478
  23. Crane CH, Ellis LM, Abbruzzese JL, et al. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol. 2006;24:1145–1151
  24. Semrad TJ, O'Donnell R, Wun T, et al. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg. 2007;106:601–608
  25. Simanek R, Vormittag R, Hassler M, et al. Venous thromboembolism and survival in patients with high-grade glioma. Neuro-Oncol. 2007;9:89–95
  26. Brandes AA, Scelzi E, Salmistraro G, et al. Incidence of risk of thromboembolism during treatment high-grade gliomas: A prospective study. Eur J Cancer. 1997;33:1592–1596
  27. Stark-Vance V. Bevacizumab (Avastin) and CPT-11 (Camptosar) in the treatment of relapsed malignant glioma. World Federation of NeuroOncology, Edinburgh, UK, May 5–8, 2005 (abstract 342).
  28. Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review. Cancer. 2000;89:640–646

 Conflict of interest: Drs. Lai and Dr. Cloughesy have served on the Scientific Advisory Board of Genentech.

PII: S0360-3016(07)04746-3

doi: 10.1016/j.ijrobp.2007.11.068

International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 5 , Pages 1372-1380 , 1 August 2008

Article Tools

* Image Usage & Resolution